Security key
88338N206
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)
CUSIP: 88338N206
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 11,676,558
- Total 13F shares
- 3,475,915
- Share change
- +1,087,880
- Total reported value
- $19,431,091
- Put/Call ratio
- 239%
- Price per share
- $5.59
- Number of holders
- 43
- Value change
- +$6,039,029
- Number of buys
- 27
- Number of sells
- 10
Report period
Q4 2022
Institutions
43
Top holders
10
TXMD full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
TherapeuticsMD, Inc. SEC filings
TherapeuticsMD, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 88338N206
Recent filing periods:
Top shareholders of TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Rubric Capital Management LP |
13F
|
Company |
9.9%
|
1,156,953
|
$7,682,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.2%
|
260,411
|
$1,729,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
1.2%
|
136,579
|
$907,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.76%
|
89,275
|
$593,000 | — | 30 Sep 2022 | |
| J. Goldman & Co LP |
13F
|
Company |
0.71%
|
82,976
|
$551,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.62%
|
72,763
|
$483,000 | — | 30 Sep 2022 | |
| SANDERS MORRIS HARRIS LLC |
13F
|
Company |
0.35%
|
40,393
|
$268,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.33%
|
38,042
|
$253,000 | — | 30 Sep 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.31%
|
36,660
|
$243,000 | — | 30 Sep 2022 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.27%
|
31,000
|
$206,000 | — | 30 Sep 2022 | |
| PEAK6 Investments LLC |
13F
|
Company |
0.21%
|
24,436
|
$162,000 | — | 30 Sep 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.19%
|
22,480
|
$149,000 | — | 30 Sep 2022 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.15%
|
17,033
|
$113,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
15,000
|
$100,000 | — | 30 Sep 2022 | |
| Asset Management Group, Inc. |
13F
|
Company |
0.13%
|
14,701
|
$98,000 | — | 30 Sep 2022 | |
| EQUITEC PROPRIETARY MARKETS, LLC |
13F
|
Company |
0.08%
|
9,100
|
$60,000 | — | 30 Sep 2022 | |
| State of Wyoming |
13F
|
Company |
0.08%
|
8,797
|
$58,000 | — | 30 Sep 2022 | |
| FMR LLC |
13F
|
Company |
0.07%
|
8,289
|
$55,000 | — | 30 Sep 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
1,643
|
$12,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,110
|
$7,000 | — | 30 Sep 2022 | |
| Cantonale Vaudoise Banque |
13F
|
Individual |
0.01%
|
1,000
|
$7,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
745
|
$5,000 | — | 30 Sep 2022 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.01%
|
600
|
$3,000 | — | 30 Sep 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
489
|
$4,000 | — | 30 Sep 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
359
|
$2,000 | — | 30 Sep 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
311
|
$2,065 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
260
|
$2,000 | — | 30 Sep 2022 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
246
|
$2,000 | — | 30 Sep 2022 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
141
|
$1,000 | — | 30 Sep 2022 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
110
|
$1,000 | — | 30 Sep 2022 | |
| American Portfolios Advisors |
13F
|
Company |
0%
|
20
|
$133 | — | 30 Sep 2022 | |
| John C.k. Milligan IV |
3/4/5
|
Secretary/CEO of subsidiary |
—
mixed-class rows
|
5,542,076
mixed-class rows
|
$12,698,322 | — | 10 May 2021 | |
| Hugh O'Dowd |
3/4/5
|
Chief Executive Officer |
—
mixed-class rows
|
4,250,000
mixed-class rows
|
$11,415,713 | — | 31 Mar 2022 | |
| Robert G. Finizio |
3/4/5
|
CEO, Director |
—
mixed-class rows
|
2,240,000
mixed-class rows
|
$5,305,888 | — | 01 Jul 2021 | |
| James Darecca |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
558,163
mixed-class rows
|
$1,857,402 | — | 10 Aug 2021 | |
| Edward Borkowski |
3/4/5
|
EVP, Operations |
—
mixed-class rows
|
560,000
mixed-class rows
|
$1,326,472 | — | 01 Jul 2021 | |
| J. Martin Carroll |
3/4/5
|
Director |
—
class O/S missing
|
106,864
|
$239,268 | — | 10 Aug 2021 | |
| Brian Bernick |
3/4/5
|
Co-Chief Executive Officer |
—
mixed-class rows
|
14,449
mixed-class rows
|
$47,065 | — | 06 Dec 2022 | |
| Angus C. Russell |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
$18,191 | — | 29 Sep 2022 | |
| Jules A. Musing |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
$18,191 | — | 29 Sep 2022 | |
| Karen Ling |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
$18,191 | — | 29 Sep 2022 | |
| Paul Bisaro |
3/4/5
|
Director |
—
class O/S missing
|
5,000
|
$18,191 | — | 29 Sep 2022 | |
| Mark A. Glickman |
3/4/5
|
Co-Chief Executive Officer |
—
mixed-class rows
|
4,760
mixed-class rows
|
$15,507 | — | 06 Dec 2022 |
Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) as of Q4 2022
As of 31 Dec 2022,
TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,475,915 shares.
The largest 10 holders included
Rubric Capital Management LP, VANGUARD GROUP INC, Tejara Capital Ltd, Clearline Capital LP, MORGAN STANLEY, BlackRock Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
29
Q4 2022 holders
43
Holder diff
14
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.